Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142340/
https://www.ncbi.nlm.nih.gov/pubmed/35637839
http://dx.doi.org/10.2147/IJN.S375352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142340/
https://www.ncbi.nlm.nih.gov/pubmed/35637839
http://dx.doi.org/10.2147/IJN.S375352

Ejemplares similares